Interview with Alfred E. Buxton, MD, and Marie-France Poulin, MD, authors of Mechanisms Underlying Alterations in Cardiac Conduction After Transcatheter Aortic Valve Replacement. Hosted by Kristen K. Patton, MD.

Related Content:

• Mechanisms Underlying Alterations in Cardiac Conduction After Transcatheter Aortic Valve Replacement

Special edition of the JAMA Editor's Summary featuring the JAMA Network articles published at the 2025 European Society of Cardiology Congress. Hosted by JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, with JAMA Executive Editor Gregory Curfman, MD, JAMA Senior Editor Philip Greenland, MD, and JAMA Cardiology Editor Robert O. Bonow, MD, MS.

Related Content:

• Remote Screening for Asymptomatic Atrial Fibrillation
• Long-Term Anticoagulation Discontinuation After Catheter Ablation for Atrial Fibrillation
• Systolic Blood Pressure and Microaxial Flow Pump–Associated Survival in Infarct-Related Cardiogenic Shock
• Helicobacter pylori Screening After Acute Myocardial Infarction
• Physiology-Guided Complete Revascularization in Older Patients With Myocardial Infarction
• Fractional Flow Reserve–Guided Complete vs Culprit-Only Revascularization in Non–ST-Elevation Myocardial Infarction and Multivessel Disease
• Transcatheter or Surgical Treatment of Patients With Aortic Stenosis at Low to Intermediate Risk
• Semaglutide and Tirzepatide in Patients With Heart Failure With Preserved Ejection Fraction
• Bivalent RSV Prefusion F Protein–Based Vaccine for Preventing Cardiovascular Hospitalizations in Older Adults
• High-Dose vs Standard-Dose Influenza Vaccine and Cardiovascular Outcomes in Older Adults
• Risk of Myocarditis or Pericarditis With High-Dose vs Standard-Dose Influenza Vaccine
• Clonal Hematopoiesis and Risk of New-Onset Myocarditis and Pericarditis
• Participation of Women in Cardiovascular Trials From 2017 to 2023
• Prevalence, Determinants, and Time Trends of Cardiovascular Health in the WHO African Region

Interview with Paul L. Hess, MD, MHS, and Vincenzo B. Polsinelli, MD, authors of Hospital Heart Failure Medical Therapy Score and Associated Clinical Outcomes and Costs. Hosted by James E. Udelson, MD.

Related Content:

• Hospital Heart Failure Medical Therapy Score and Associated Clinical Outcomes and Costs

Interview with James A. de Lemos, MD, and Ambarish Pandey, MD, authors of Association of US Centers for Medicare and Medicaid Services Hospital 30-Day Risk-Standardized Readmission Metric With Care Quality and Outcomes After Acute Myocardial Infarction: Findings From the National Cardiovascular Data Registry/Acute Coronary Treatment and Intervention Outcomes Network Registry–Get With the Guidelines

Interview with Laura Mauri, MD, MSc, author of Mortality Following Cardiovascular and Bleeding Events Occurring Beyond 1 Year After Coronary Stenting: A Secondary Analysis of the Dual Antiplatelet Therapy (DAPT) Study

Interview with Carolyn Y. Ho, MD, author of The Burden of Early Phenotypes and the Influence of Wall Thickness in Hypertrophic Cardiomyopathy Mutation Carriers: Findings From the HCMNet Study, and Jil C. Tardiff, MD, PhD, author of Assessing the Phenotypic Burden of Preclinical Sarcomeric Hypertrophic Cardiomyopathy—New Assessments to Guide Diagnosis and Management

Interview with Fatima Rodriguez, MD, MPH, author of Disaggregation of Cause-Specific Cardiovascular Disease Mortality Among Hispanic Subgroups

Interview with Martha L. Daviglus, MD, PhD, author of Challenges in Assessing Cardiovascular Mortality Among Hispanic/Latino Groups in the United States

Interview with Euan A. Ashley, MRCP, DPhil, author of Feasibility of Obtaining Measures of Lifestyle From a Smartphone App, Bonnie Spring, PhD, author of First Steps Into the Brave New Transdiscipline of Mobile Health, and C Michael Gibson, MD, MS, author of The Democratization of Medical Research and Education Through Social Media

Interview with Thenappan Thenappan, MD, author of Trends and Outcomes of Pulmonary Arterial Hypertension–Related Hospitalizations in the United States: Analysis of the Nationwide Inpatient Sample Database From 2001 Through 2012, Bradley A. Maron, MD, author of Pulmonary Arterial Hypertension in the Contemporary Era, and Vallerie V. McLaughlin, MD, author of Burden of Pulmonary Arterial Hypertension

Interview with Paul A. Heidenreich, MD, MS and Fatima Rodriguez, MD, MPH, authors of Association Between Intensity of Statin Therapy and Mortality in Patients With Atherosclerotic Cardiovascular Disease

Elizabeth M. McNally, MD, PhD interviews Taulant Muka, MD, MSc, DSc, author of Association of Age at Onset of Menopause and Time Since Onset of Menopause With Cardiovascular Outcomes, Intermediate Vascular Traits, and All-Cause Mortality, JoAnn E. Manson, MD, DrPH and Teresa K. Woodruff, PhD, authors of Reproductive Health as a Marker of Subsequent Cardiovascular Disease

Interview with Marc Bonaca, MD, author of Antiplatelet Therapy for Long-term Secondary Prevention After Myocardial Infarction, and John Bittl, MD, author of Extended Dual Antiplatelet Therapy in Patients With Prior Myocardial Infarction

Interview with Luis R. Lopes, PhD, author of Prevalence, Cardiac Phenotype, and Outcomes of Transthyretin Variants in the UK Biobank Population, and Senthil Selvaraj, MD, MS, MA, author of Genotype- vs Phenotype-Guided Approaches to Improve ATTR Detection. Hosted by Sharlene M. Day, MD.

Related Content:

• Prevalence, Cardiac Phenotype, and Outcomes of Transthyretin Variants in the UK Biobank Population
• Genotype- vs Phenotype-Guided Approaches to Improve ATTR Detection

Clyde W. Yancy, MD interviews Sripal Bangalore, MD, MHA, author of Rates of Invasive Management of Cardiogenic Shock in New York Before and After Exclusion From Public Reporting, James M. McCabe, MD, author of Treatment and Outcomes of Acute Myocardial Infarction Complicated by Shock After Public Reporting Policy Changes in New York, and Ajay J. Kirtane, MD, SM, author of The Complicated Calculus of Publicly Reporting Mortality After Percutaneous Coronary Intervention

Interview with Marc Bonaca, MD, MPH, author of Long-term Tolerability of Ticagrelor for the Secondary Prevention of Major Adverse Cardiovascular Events: A Secondary Analysis of the PEGASUS-TIMI 54 Trial, and Christopher Granger, MD, author of Understanding the Adverse Effects of Ticagrelor in Practice

Interview with Edward Carlton, PhD, author of Evaluation of High-Sensitivity Cardiac Troponin I Levels in Patients With Suspected Acute Coronary Syndrome, and David Morrow, MD, MPH, author of Evidence-Based Algorithms Using High-Sensitivity Cardiac Troponin in the Emergency Department

Interview with Erica Spatz, MD, MHS, author of Geographic Variation in Trends and Disparities in Acute Myocardial Infarction Hospitalization and Mortality by Income Levels, 1999-2013, and Thomas Maddox, MD, MSc, and Karen Joynt, MD, MPH, authors of Looking Beyond the Hospital to Reduce Acute Myocardial Infarction: Progress and Potential

Interview with Bentley J. Bobrow, MD, author of Implementation of a Regional Telephone Cardiopulmonary Resuscitation Program and Outcomes After Out-of-Hospital Cardiac Arrest

Interview with Darren McGuire, MD, author of Association Between Sitagliptin Use and Heart Failure Hospitalization and Related Outcomes in Type 2 Diabetes Mellitus, and Benjamin Scirica, MD, author of The Safety of Dipeptidyl Peptidase 4 Inhibitors and the Risk for Heart Failure

Interview with Jonathan Hsu, MD, MAS, author of Oral Anticoagulant Therapy Prescription in Patients With Atrial Fibrillation Across the Spectrum of Stroke Risk, and Gregg Fonarow, MD, author of Preventing Stroke in Patients With Atrial Fibrillation—A Steep Climb Away From Achieving Peak Performance.

Editors' Summary by Robert Bonow, MD, Editor in Chief of JAMA Cardiology, for  February 24, 2016, with Deputy Editors Robert Harrington, MD, Marc Sabatine, MD, Clyde Yancy, MD, and Michael Pencina, PhD

Interview with Jagmeet P. Singh, MD, DPhil, author of Leadless Ultrasound-Based Cardiac Resynchronization System in Heart Failure. Hosted by Kristen K. Patton, MD.

Related Content:

• Leadless Ultrasound-Based Cardiac Resynchronization System in Heart Failure

Interview with Alisse Hauspurg, MD, MS, author of Postpartum Ambulatory Blood Pressure Patterns Following New-Onset Hypertensive Disorders of Pregnancy. Hosted by Sadiya S. Khan, MD, MSc.

Related Content:

• Postpartum Ambulatory Blood Pressure Patterns Following New-Onset Hypertensive Disorders of Pregnancy

Interview with Jonathan Afilalo, MD, MSc, author of Osteosarcopenia and Mortality in Older Adults Undergoing Transcatheter Aortic Valve Replacement. Hosted by Robert O. Bonow, MD.

Related Content:

• Osteosarcopenia and Mortality in Older Adults Undergoing Transcatheter Aortic Valve Replacement

Interview with Sanjiv J. Shah, MD, author of Atrial Shunt Device Effects on Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction: The REDUCE LAP-HF II Randomized Clinical Trial. Hosted by James E. Udelson, MD.

Related Content:

• Atrial Shunt Device Effects on Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction

Interview with Gaurav A. Upadhyay, MD, and Jeremy S. Treger, MD, PhD, authors of A Revised Definition of Left Bundle Branch Block Using Time to Notch in Lead I. Hosted by Kristen K. Patton, MD.

Related Content:

• A Revised Definition of Left Bundle Branch Block Using Time to Notch in Lead I

Interview with Michael T. Lu, MD, MPH, author of Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV: Mechanistic Substudy of the REPRIEVE Randomized Clinical Trial, and Matthew J. Feinstein, MD, MSc, author of Statins, Inflammation, and Tissue Context in REPRIEVE. Hosted by Robert Bonow, MD.

Related Content:

• Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV
• Statins, Inflammation, and Tissue Context in REPRIEVE

Interview with Sanjiv J. Shah, MD, author of Effect of Tafamidis on Cardiac Function in Patients With Transthyretin Amyloid Cardiomyopathy: A Post Hoc Analysis of the ATTR-ACT Randomized Clinical Trial. Hosted by James E. Udelson, MD.

Related Content:

• Effect of Tafamidis on Cardiac Function in Patients With Transthyretin Amyloid Cardiomyopathy

Interview with Divaka Perera, MA, MD, author of Viability and Outcomes With Revascularization or Medical Therapy in Ischemic Ventricular Dysfunction: A Prespecified Secondary Analysis of the REVIVED-BCIS2 Trial, and Julio A. Panza, MD, author of Assessment of Myocardial Viability in Ischemic Cardiomyopathy—Scarred by the Data but Still Alive. Hosted by James E. Udelson, MD.

Related Content:

• Viability and Outcomes With Revascularization or Medical Therapy in Ischemic Ventricular Dysfunction
• Assessment of Myocardial Viability in Ischemic Cardiomyopathy—Scarred by the Data but Still Alive

Interview with Frederick L. Ruberg, MD, and Mathew S. Maurer, MD, authors of Transthyretin Cardiac Amyloidosis in Older Black and Hispanic Individuals With Heart Failure. Hosted by Sadiya Khan, MD.

Related Content:

• Transthyretin Cardiac Amyloidosis in Older Black and Hispanic Individuals With Heart Failure

Interview with Muthiah Vaduganathan, MD, MPH, and John W. Ostrominski, MD, authors of Prevalence and Overlap of Cardiac, Renal, and Metabolic Conditions in US Adults, 1999-2020. Hosted by Sadiya Sana Khan, MD, MSc.

Related Content:

• Prevalence and Overlap of Cardiac, Renal, and Metabolic Conditions in US Adults, 1999-2020

Interview with Maria C. Magnus, PhD, author of Maternal Risk of Cardiovascular Disease After Use of Assisted Reproductive Technologies, and Sadiya S. Khan, MD, MSc, author of Assisted Reproductive Technologies and Cardiovascular Disease Risk in Birthing Adults—When Null Results Matter. Hosted by Roxana Mehran, MD

Related Content:

• Maternal Risk of Cardiovascular Disease After Use of Assisted Reproductive Technologies
• Assisted Reproductive Technologies and Cardiovascular Disease Risk in Birthing Adults—When Null Results Matter

Interview with Marianna Fontana, MD, PhD, author of Tracking Treatment Response in Cardiac Light-Chain Amyloidosis With Native T1 Mapping, and Sarah A. M. Cuddy, MB, BCh, BAO, author of Imaging Biomarkers in the Management of Light-Chain Cardiac Amyloidosis. Hosted by James Udelson, MD.

Related Content:

• Tracking Treatment Response in Cardiac Light-Chain Amyloidosis With Native T1 Mapping
• Imaging Biomarkers in the Management of Light-Chain Cardiac Amyloidosis

Interview with Robert W. Yeh, MD, MSc, author of Comparative Effectiveness of Percutaneous Microaxial Left Ventricular Assist Device vs Intra-Aortic Balloon Pump or No Mechanical Circulatory Support in Patients With Cardiogenic Shock, and David J. Cohen, MD, MSc, and Manesh R. Patel, MD, authors of Evidence Generation for Novel Cardiovascular Devices—Putting the Horse Back in Front of the Cart. Hosted by Ajay J. Kirtane, MD, SM.

Related Content:

• Comparative Effectiveness of Percutaneous Microaxial Left Ventricular Assist Device vs Intra-Aortic Balloon Pump or No Mechanical Circulatory Support in Patients With Cardiogenic Shock
• Evidence Generation for Novel Cardiovascular Devices—Putting the Horse Back in Front of the Cart

Interview with Sharlene M. Day, MD, Rachel Lampert, MD, and Michael J. Ackerman, MD, PhD, authors of Vigorous Exercise in Patients With Hypertrophic Cardiomyopathy. Hosted by Robert Bonow, MD.

Related Content:

• Vigorous Exercise in Patients With Hypertrophic Cardiomyopathy

Interview with Ajay J. Kirtane, MD, SM, author of Patient-Level Pooled Analysis of Ultrasound Renal Denervation in the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO Trials. Hosted by Clyde W. Yancy, MD, MSc.

Related Content:

• Patient-Level Pooled Analysis of Ultrasound Renal Denervation in the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO Trials
• Is There a Role for Renal Denervation in the Treatment of Hypertension?

Interview with Jenica N. Upshaw, MD, MS, author of Association of Preexisting Heart Failure With Outcomes in Older Patients With Diffuse Large B-Cell Lymphoma, and Ana Barac, MD, PhD, author of Assessing Heart Failure vs Lymphoma Treatment Risks and Benefits—It Takes Two to Tango. Hosted by Robert Bonow, MD.

Related Content:

• Association of Preexisting Heart Failure With Outcomes in Older Patients With Diffuse Large B-Cell Lymphoma
• Assessing Heart Failure vs Lymphoma Treatment Risks and Benefits—It Takes Two to Tango

Interview with Søren Zöga Diederichsen, MD, PhD, author of Prevalence and Prognostic Significance of Bradyarrhythmias in Patients Screened for Atrial Fibrillation vs Usual Care: Post Hoc Analysis of the LOOP Randomized Clinical Trial, and Mark Schoenfeld, MD, author of Incidental Detection of Bradycardia by Implantable Loop Recorders—Unintended Consequences. Hosted by Kristen K. Patton, MD.

Related Content:

• Prevalence and Prognostic Significance of Bradyarrhythmias in Patients Screened for Atrial Fibrillation vs Usual Care
• Incidental Detection of Bradycardia by Implantable Loop Recorders—Unintended Consequences

Interview with Michael J. Reardon, MD, and Daniel O'Hair, MD, authors of Structural Valve Deterioration After Self-Expanding Transcatheter or Surgical Aortic Valve Implantation in Patients at Intermediate or High Risk. Hosted by Robert O. Bonow, MD, MS.

Related Content:

• Structural Valve Deterioration After Self-Expanding Transcatheter or Surgical Aortic Valve Implantation in Patients at Intermediate or High Risk

Interview with Mitesh S. Patel, MD, MBA, author of Effect of Nudges to Clinicians, Patients, or Both to Increase Statin Prescribing: A Cluster Randomized Clinical Trial, and Faraz S. Ahmad, MD, MS, author of Nudging to Improve Cardiovascular Care—Clinicians, Patients, or Both. Hosted by Sadiya Sana Khan, MD, MS.

Related Content:

• Effect of Nudges to Clinicians, Patients, or Both to Increase Statin Prescribing
• Nudging to Improve Cardiovascular Care—Clinicians, Patients, or Both

Interview with Margaret Infeld, MD, MS, author of Clinical Outcomes With Personalized Accelerated Physiologic Pacing in Heart Failure With Preserved Ejection Fraction: Follow-Up of the myPACE Trial. Hosted by Robert Bonow, MD.

Related Content:

• Clinical Outcomes With Personalized Accelerated Physiologic Pacing in Heart Failure With Preserved Ejection Fraction

JAMA Interim Executive Editor Gregory Curfman, MD, interviews Robert M. Carey, MD, University of Virginia, about his review article on treatment of hypertension in the November 8, 2022, issue of JAMA. Their discussion addresses the clinical consequences of hypertension, as well as nonpharmacological and pharmacological approaches to management, including patients with resistant hypertension.

Related Content:

• Treatment of Hypertension

More programs like this one are available via the JAMA Clinical Reviews podcast.

Interview with Nicholas M. Pajewski, PhD, author of Longer-Term All-Cause and Cardiovascular Mortality With Intensive Blood Pressure Control: A Secondary Analysis of a Randomized Clinical Trial, and Daniel W. Jones, MD, author of Blood Pressure Control After SPRINT—Back to Reality. Hosted by Gregg C. Fonarow, MD.

Related Content:

• Longer-Term All-Cause and Cardiovascular Mortality With Intensive Blood Pressure Control
• Blood Pressure Control After SPRINT—Back to Reality

Interview with Santhi K. Ganesh, MD, author of Burden of Rare Genetic Variants in Spontaneous Coronary Artery Dissection With High-risk Features, and Sharonne N. Hayes, MD, author of Genetic Testing in High-risk Spontaneous Coronary Artery Dissection—Searching for Clinical Utility Among Background Genetic Noise. Hosted by Sadiya Sana Khan, MD, MS.

Related Content:

• Burden of Rare Genetic Variants in Spontaneous Coronary Artery Dissection With High-risk Features
• Genetic Testing in High-risk Spontaneous Coronary Artery Dissection—Searching for Clinical Utility Among Background Genetic Noise

Interview with Tariq Ahmad, MD, MPH, author of Alerting Clinicians to 1-Year Mortality Risk in Patients Hospitalized With Heart Failure: The REVEAL-HF Randomized Clinical Trial, and Rishi K. Wadhera, MD, MPP, MPhil, author of Improving Quality Improvement—From Aspiration Toward Empiricism. Hosted by Gregg C. Fonarow, MD.

Related Content:

• Alerting Clinicians to 1-Year Mortality Risk in Patients Hospitalized With Heart Failure
• Improving Quality Improvement—From Aspiration Toward Empiricism

Interview with João L. Cavalcante, MD, author of Association of Left Ventricular Remodeling Assessment by Cardiac Magnetic Resonance With Outcomes in Patients With Chronic Aortic Regurgitation, and Vidhu Anand, author of Earlier Intervention in Asymptomatic Chronic Aortic Regurgitation—Novel Indicators of Myocardial Overload.Hosted by Robert Bonow, MD.

Interview with Ambarish Pandey, MD, MSCS, author of Machine Learning–Based Models Incorporating Social Determinants of Health vs Traditional Models for Predicting In-Hospital Mortality in Patients With Heart Failure, and Eldrin F. Lewis, MD, MPH, author of Machine Learning and Social Determinants of Health—An Opportunity to Move Beyond Race for Inpatient Risk Prediction in Patients With Heart Failure. Hosted by Clyde W. Yancy, MD.

Related Content:

• Machine Learning–Based Models Incorporating Social Determinants of Health vs Traditional Models for Predicting In-Hospital Mortality in Patients With Heart Failure
• Machine Learning and Social Determinants of Health—An Opportunity to Move Beyond Race for Inpatient Risk Prediction in Patients With Heart Failure

In July 2022, Kirsten Bibbins-Domingo, PhD, MD, MAS, took on a new role as the 17th editor in chief of JAMA and the JAMA Network. In conversation with Nobel laureate Harold Varmus, MD, Bibbins-Domingo discusses her research background, approaches to leadership in health care, and the critical role that journals play in communication about public health and science.

Related Content:

• The Urgency of Now and the Responsibility to Do More—My Commitment for JAMA and the JAMA Network
• A Conversation With Dr Kirsten Bibbins-Domingo, JAMA's New Editor in Chief (video)
• A Conversation With Dr Kirsten Bibbins-Domingo, JAMA's New Editor in Chief (audio)

Interview with Aniruddh P. Patel, MD, author of Association of Pathogenic DNA Variants Predisposing to Cardiomyopathy With Cardiovascular Disease Outcomes and All-Cause Mortality, and M. Benjamin Shoemaker, MD, author of Mortality Among Patients With Early-Onset Atrial Fibrillation and Rare Variants in Cardiomyopathy and Arrhythmia Genes. Hosted by Sadiya Sana Khan, MD, MS.